Today: 22 March 2026
Browse Category

Financial Forecasts 22 December 2025

Edgewise Therapeutics (EWTX) Stock News Today: What’s Driving the Volatility, Analyst Forecasts, and Key Catalysts (Dec. 22, 2025)

Edgewise Therapeutics (EWTX) Stock News Today: What’s Driving the Volatility, Analyst Forecasts, and Key Catalysts (Dec. 22, 2025)

Edgewise Therapeutics shares swung between $27.77 and $21.18 on Dec. 22, closing at $21.29 with volume over one million. The volatility followed a 20.8% surge on Dec. 19 and mixed analyst commentary, including JPMorgan raising its price target to $34 despite concerns over a $40.67 million quarterly loss.
Viasat (VSAT) Stock Today: Price Jumps as ViaSat-3 Expansion, Ka-Band Defense Network, and Analyst Forecasts Shape 2026 Outlook (Dec. 22, 2025)

Viasat (VSAT) Stock Today: Price Jumps as ViaSat-3 Expansion, Ka-Band Defense Network, and Analyst Forecasts Shape 2026 Outlook (Dec. 22, 2025)

Viasat shares rose about 7% to $36.16 by midday Monday, Dec. 22, 2025, after the company released a year-in-review update. The recap highlighted the November launch of ViaSat-3 F2, plans for expanded capacity in 2026, and over 2,000 maritime orders for its NexusWave system. The stock traded between the mid-$34s and mid-$36s during the session.
Lululemon Stock (LULU) Today: Elliott’s $1B Stake, CEO Shake-Up, New 2026 Expansion—and What Wall Street Forecasts Next (Dec. 22, 2025)

Lululemon Stock (LULU) Today: Elliott’s $1B Stake, CEO Shake-Up, New 2026 Expansion—and What Wall Street Forecasts Next (Dec. 22, 2025)

Lululemon shares traded near $211 on Dec. 22, up 0.8%, as investors reacted to CEO Calvin McDonald’s planned departure and news of Elliott Management’s $1 billion-plus stake. Meghan Frank and André Maestrini will serve as interim co-CEOs starting Jan. 31. The company also announced expansion into six new international markets in 2026.
Zenas BioPharma (ZBIO) Stock Hits a Record High on Dec. 22, 2025 as INDIGO Phase 3 Catalyst Nears — Latest News, Analyst Forecasts, and What’s Next

Zenas BioPharma (ZBIO) Stock Hits a Record High on Dec. 22, 2025 as INDIGO Phase 3 Catalyst Nears — Latest News, Analyst Forecasts, and What’s Next

Zenas BioPharma shares jumped about 14% to $41.23 on December 22, 2025, hitting a record high of $41.67 ahead of expected Phase 3 INDIGO trial results for obexelimab in IgG4-related disease. Citi and Wedbush both reiterated bullish ratings and price targets, citing the upcoming clinical data as a near-term catalyst.
22 December 2025
Rigetti Computing Stock (RGTI) News Today, Dec. 22, 2025: Shares Surge as Analyst Forecasts for 2026 Focus on Roadmap, Cash Runway, and High-Volatility Risks

Rigetti Computing Stock (RGTI) News Today, Dec. 22, 2025: Shares Surge as Analyst Forecasts for 2026 Focus on Roadmap, Cash Runway, and High-Volatility Risks

Rigetti Computing (RGTI) shares rose about 14% to $27 on Monday, December 22, 2025, amid renewed interest in quantum-computing stocks. The surge followed a wave of analyst coverage, including a Zacks report forecasting a quarterly loss and rating the stock as expensive, and a TipRanks summary noting a Wedbush $35 price target for 2026.
UniFirst Corporation Stock (UNF) Jumps After Cintas Renews $275 Buyout Offer — News, Forecasts, and What’s Next

UniFirst Corporation Stock (UNF) Jumps After Cintas Renews $275 Buyout Offer — News, Forecasts, and What’s Next

Cintas Corporation made a $5.2 billion all-cash offer to acquire UniFirst at $275 per share, its third attempt to buy the company. UniFirst confirmed receipt of the non-binding proposal and said its board is reviewing the bid. UniFirst shares jumped 18% to $201 after the news, well below the offer price. Cintas included a $350 million reverse termination fee if regulators block the deal.
Applied Optoelectronics (AAOI) Stock Jumps on 800G Hyperscaler Momentum: Dec. 22, 2025 News, Analyst Forecasts, and Outlook

Applied Optoelectronics (AAOI) Stock Jumps on 800G Hyperscaler Momentum: Dec. 22, 2025 News, Analyst Forecasts, and Outlook

Applied Optoelectronics shares jumped 14% to 16% intraday Monday, trading near $36, after news of its first volume order for 800G data center transceivers from a major hyperscale customer. The company expects 800G shipments to add $4 million to $8 million in Q4 revenue. AAOI also reported $22 million in 400G orders year-to-date.
UPS Stock Outlook for 2026: 6.5% Dividend, Cost Cuts, Rate Hikes—and the Biggest Risks in the Next Year

UPS Stock Outlook for 2026: 6.5% Dividend, Cost Cuts, Rate Hikes—and the Biggest Risks in the Next Year

UPS shares hovered near $100 on Dec. 22, with a dividend yield around 6.5%, drawing both interest and concern over payout sustainability. Investors are focused on UPS’s efforts to boost profitability by cutting low-margin business, including a deal to reduce Amazon package volume by over 50% by late 2026. Analysts flagged uncertainty over 2026 demand and the impact of new surcharges on pricing.
Carnival Corporation & plc Stock (CCL) Today: Dividend Return, Strong 2026 Forecast, and NYSE-Only Unification Plan Drive Fresh Buzz

Carnival Corporation & plc Stock (CCL) Today: Dividend Return, Strong 2026 Forecast, and NYSE-Only Unification Plan Drive Fresh Buzz

Carnival Corporation reported fiscal Q4 2025 net income of $422 million and adjusted EPS of $0.34, beating consensus estimates. Shares jumped as much as 10.2% after the company reinstated its dividend and issued upbeat 2026 guidance. Full-year 2025 revenue reached a record $26.6 billion. Carnival forecast adjusted net income of about $3.45 billion for 2026.
Palantir Stock (PLTR) News Today: Shares Jump on Dec. 22, 2025 as Navy ShipOS, Nvidia Partnership, and 2026 Forecasts Collide

Palantir Stock (PLTR) News Today: Shares Jump on Dec. 22, 2025 as Navy ShipOS, Nvidia Partnership, and 2026 Forecasts Collide

Palantir Technologies shares rose 4.18% to $193.38 as of 14:27 UTC Monday, trading near their 52-week high. The move followed renewed investor focus on AI and defense contracts, despite ongoing scrutiny over Palantir’s valuation and UK lawmakers questioning its government deals after a Swiss security report. Trading volume reached about 19.23 million shares.
Pfizer Stock Outlook for 2026: Oncology Momentum, Obesity Deals, and the Patent Cliff Investors Can’t Ignore

Pfizer Stock Outlook for 2026: Oncology Momentum, Obesity Deals, and the Patent Cliff Investors Can’t Ignore

Pfizer on Dec. 22 announced a new metastatic prostate cancer research program with Flagship Pioneering and Repertoire Immune Medicines, the eighth under their alliance. The move follows Pfizer’s Dec. 16 guidance projecting flat-to-down 2026 revenue, ongoing COVID product declines, and increased R&D spending. Management warned of “bumpy” years ahead as exclusivity losses weigh on sales.
Microsoft Stock (MSFT) News Today: AI “Copilot” Push, Azure Growth, and Wall Street’s 2026 Forecasts (Dec. 22, 2025)

Microsoft Stock (MSFT) News Today: AI “Copilot” Push, Azure Growth, and Wall Street’s 2026 Forecasts (Dec. 22, 2025)

Microsoft shares traded near $486 on December 22, 2025, holding above spring lows but below the July peak of $555.45. Analysts at Wedbush and Evercore highlighted optimism for AI-driven growth and Azure in 2026. CEO Satya Nadella is reportedly pushing for faster Copilot improvements. A year-end tech rebound is supporting sentiment across AI stocks.
Datavault AI (DVLT) Stock News Today: New Blockchain Patents, 2026 Revenue Forecasts, and the Catalysts Moving Shares (Dec. 22, 2025)

Datavault AI (DVLT) Stock News Today: New Blockchain Patents, 2026 Revenue Forecasts, and the Catalysts Moving Shares (Dec. 22, 2025)

Datavault AI announced two new U.S. patents on Dec. 22 for blockchain-based content licensing and tokenized monetization. Shares traded near $0.97 early Monday, down about 9.6% from the prior close, with volume spiking to around 94 million shares. The company’s stock has swung between $0.25 and $4.10 over the past year.
BP PLC Stock Outlook (Dec. 22, 2025): New CEO Meg O’Neill, Buybacks, and 2026 Oil Price Forecasts Put BP Shares in Focus

BP PLC Stock Outlook (Dec. 22, 2025): New CEO Meg O’Neill, Buybacks, and 2026 Oil Price Forecasts Put BP Shares in Focus

BP confirmed Meg O’Neill will become CEO on April 1, 2026, following Murray Auchincloss’s abrupt exit. Shares traded at 424.5p in London and $33.94 in New York as of December 22. The board is pushing for tighter cost controls and asset sales amid persistent takeover speculation. BP is running active share buybacks while oil prices remain range-bound.
1 6 7 8 9 10 42
Go toTop